SE
27
-14
MHK
55
7
HCA
60
3
CME
42
5
BK
72
3
VRSN
53
3
GRMN
67
2
EIX
58
4
PNR
71
2
EQR
45
-3
HD
54
2
BSX
57
-6
PEP
48
4
IPG
43
4
INTU
65
2
SCHW
45
3
DAL
42
2
C
50
2
TMO
59
-7
ADM
36
2
SE
27
-14
MHK
55
7
HCA
60
3
CME
42
5
BK
72
3
VRSN
53
3
GRMN
67
2
EIX
58
4
PNR
71
2
EQR
45
-3
HD
54
2
BSX
57
-6
PEP
48
4
IPG
43
4
INTU
65
2
SCHW
45
3
DAL
42
2
C
50
2
TMO
59
-7
ADM
36
2
Financhill
Back

Gilead Sciences Quote, Financials, Valuation and Earnings

Wall Street's Worst Nightmare: Small Town Trader's AI Edge

See the AI advantage for everyday Americans.
Sell
49

GILD
Gilead Sciences

Last Price:
77.01
Seasonality Move:
9.03%

7 Day Trial

ALL ACCESS PASS

$ 7

$1,300 into $45,000 in just 4 MONTHS?!

See here to see the full details.

Gilead Sciences Price Quote

$77.01
+0.48 (+0.63%)
(Updated: July 26, 2024 at 6:55 PM ET)

Gilead Sciences Key Stats

Sell
49
Gilead Sciences (GILD) is a Sell
Day range:
$75.74 - $78.29
52-week range:
$62.07 - $87.87
Dividend yield:
3.97%
P/E ratio:
17.01
P/S ratio:
3.50
P/B ratio:
5.44%
Volume:
10.1M
Avg. volume:
8.1M
1-year change:
-0.91%
Market cap:
$95.3B
Revenue:
$27.1B
EPS:
$0.36

How Much Does Gilead Sciences Make?

Is Gilead Sciences Growing As A Company?

  • What Is Gilead Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.05%
  • What Is Gilead Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Gilead Sciences Stock Price Performance

  • Did Gilead Sciences Stock Go Up Last Month?
    Gilead Sciences share price went up by 9.94% last month
  • Did GILD's Share Price Rise Over The Last Year?
    GILD share price fell by -0.91% over the past 1 year

What Is Gilead Sciences 52-Week High & Low?

Gilead Sciences Price To Free Cash Flow

Is It Risky To Buy Gilead Sciences?

  • How Much Debt Does Gilead Sciences Have?
    Total long term debt quarterly is $25.2B
  • How Much Cash Does Gilead Sciences Have?
    Cash and short term investments quarterly total is $4.7B
  • What Is Gilead Sciences’s Book Value Per Share?
    Book value per share is 14.07

Is Gilead Sciences Cash Flow Positive?

  • What Is GILD Cash Flow From Operations?
    Cash flow from operations (TTM) is $8.5B
  • What Is Gilead Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.1B
  • What Is Gilead Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.6B

Gilead Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    GILD return on invested capital is 1.05%
  • What Is Gilead Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is 0.79%
  • What Is GILD Return On Equity?
    ROE is a measure of profitability and is 2.32%

Gilead Sciences Earnings Date & Stock Price

Gilead Sciences Competitors

  • Who Are Gilead Sciences's Competitors?
    Below is a list of companies who compete with Gilead Sciences or are related in some way:
    • AbbVie Inc (ABBV)
    • Amgen Inc (AMGN)
    • Bristol-Myers Squibb Co (BMY)
    • Pfizer Inc (PFE)
    • Arcus Biosciences Inc (RCUS)

Gilead Sciences Dividend Yield

Gilead Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 13.11%
Revenue: 5.26% 5.31%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 15
Sell Recommendations: 1
Price Target: 82.47
Upside from Last Price: 7.76%

Major Shareholders

  • How many GILD shares are owned by institutional investors?
    1.7B GILD shares are owned by institutional investors
  • How many GILD shares are owned by insiders?
    8.4M GILD shares are owned by insiders